These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5571114)

  • 1. Cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-dopa.
    Wilk S; Mones R
    J Neurochem; 1971 Sep; 18(9):1771-3. PubMed ID: 5571114
    [No Abstract]   [Full Text] [Related]  

  • 2. 3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
    Gordon EK; Oliver J
    Clin Chim Acta; 1971 Nov; 35(1):145-50. PubMed ID: 4256760
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid homovanillic acid and iso-homovanillic acid: a gas-liquid chromatographic method.
    Dziedzic SW; Gitlow SE
    J Neurochem; 1974 Mar; 22(3):333-5. PubMed ID: 4829959
    [No Abstract]   [Full Text] [Related]  

  • 4. The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.
    Curzon G; Godwin-Austen RB; Tomlinson EB; Kantamaneni BD
    J Neurol Neurosurg Psychiatry; 1970 Feb; 33(1):1-6. PubMed ID: 5418176
    [No Abstract]   [Full Text] [Related]  

  • 5. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
    Chase TN; Gordon EK; Ng LK
    J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
    [No Abstract]   [Full Text] [Related]  

  • 6. L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism.
    Weiner W; Harrison W; Klawans H
    Life Sci; 1969 Sep; 8(17):971-6. PubMed ID: 5808572
    [No Abstract]   [Full Text] [Related]  

  • 7. Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.
    Godwin-Austen RB
    J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):219-23. PubMed ID: 5571307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal homovanillic acid and parkinsonism.
    Miachon S; Dalmaz Y; Cottet-Emard JM; Peyrin L
    Biomedicine; 1974 Jul; 21(7):303-8. PubMed ID: 4433665
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
    Johansson B; Roos BE
    Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlations between a fluorimetric and mass fragmentographic method for the determination of 3-methoxy-4-hydroxyphenylacetic acid and two mass fragmentographic methods for the determination of 3-methoxy-4- hydroxyphenylethylene glycol in cerebrospinal fluid.
    Muskiet FA; Jeuring HJ; Korf J; Sedvall G; Westerink BH; Teelken AW; Wolthers BG
    J Neurochem; 1979 Jan; 32(1):191-4. PubMed ID: 759571
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa).
    Sharpless NS; Ericsson AD; McCann DS
    Neurology; 1971 May; 21(5):540-9. PubMed ID: 5104098
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinsonism-dementia of Guam: treatment with L-dopa.
    Schnur JA; Chase TN; Brody JA
    Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247
    [No Abstract]   [Full Text] [Related]  

  • 13. The determination of 4-hydroxy-3-methoxyphenylethylene glycol in urine and CSF using gas chromatography.
    Bond PA
    Biochem Med; 1972 Feb; 6(1):36-45. PubMed ID: 4260101
    [No Abstract]   [Full Text] [Related]  

  • 14. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
    van Woert MH; Bowers MB
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
    Chase TN
    Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid.
    Wilk S; Davis KL; Thacker SB
    Anal Biochem; 1971 Feb; 39(2):498-504. PubMed ID: 4325071
    [No Abstract]   [Full Text] [Related]  

  • 17. Serial determinations of homovanillinic acid in the cerebrospinal fluid of Parkinson patients treated with L-dopa.
    Bertler A; Jeppsson PG; Nordgren L; Rosengren E
    Acta Neurol Scand; 1971; 47(4):393-402. PubMed ID: 4941731
    [No Abstract]   [Full Text] [Related]  

  • 18. Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease.
    Ebinger G; Adriaenssens K
    Clin Chim Acta; 1973 Nov; 48(4):427-31. PubMed ID: 4761590
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
    Voto Bernales J; Cruz GA; Davila E
    Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
    [No Abstract]   [Full Text] [Related]  

  • 20. Accumulation of 3-methoxy-4-hydroxyphenylglycol-sulfate in rabbit cerebrospinal fluid following probenecid.
    Extein I; Korf J; Roth RH; Bowers MB
    Brain Res; 1973 May; 54():403-7. PubMed ID: 4709155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.